Vetter inks ‘pain-free’ needle deal to meet alternative drug delivery demand
Vetter Pharma has signed a strategic agreement to develop Microdermics’ microneedle drug delivery technology.
Vetter Pharma has signed a strategic agreement to develop Microdermics’ microneedle drug delivery technology.
The AAALAC has inspected Envigo's isolator breeding facility in India, which the contract research organization says is an important growth market.
With or without a preferred provider – what do pharma sponsors look for in a contract research organization?
Following its proposed LabAnswer acquisition, Accenture will form a scientific informatics service division, which it said will enable new patient treatments with “new insights into human biology.”
Q&A with the 'Medical Futurist'
3D printing, augmented reality and deep learning algorithms will shape the future of the pharmaceutical supply chain says Dr Bertalan Mesko, the Medical Futurist.